Patient Access Insights

How can we accelerate patient access?
Reducing delays in horizon scanning, topic selection and prioritisation.

In this webinar, Christian Hill, CEO of MAP BioPharma, provides an overview on how to accelerate patient access by reducing delays in horizon scanning. He also considers how to influence the process so you can improve the likelihood of a favourable outcome for your company.
Request this webinar

How can we accelerate patient access?
Reducing delays in horizon scanning, topic selection and prioritisation.

Originally broadcast: Monday, 20th July 2020

Duration: 60 minutes. Available to watch on demand

Learning objectives:

  •  How products get highlighted to NICE and how NICE decides which topics to select

  •  How the voluntary pricing scheme affects the likelihood of topic selection and the challenge this creates for NICE

  •  The impact of COVID-19 on appraisals and the plan for the rest of 2020 and 2021

  •  How to influence the process so you can improve the likelihood of getting what you want

  •  What questions relate to horizon scanning and the several things this term actually involves.


Christian%201x
Christian Hill

Chief Executive Officer

Terms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2020. MAP BioPharma Limited. All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

+44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales. Company Registration Number 08209281

VAT Group Registration Number GB 292 8576 52